...
首页> 外文期刊>Molecular and Biochemical Parasitology >dhfr N51, C59, S108 – dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso]]>
【24h】

dhfr N51, C59, S108 – dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso]]>

机译:DHFR N51,C59,S108 - DHPS A437,Plasmodium疟原虫中的K540突变来自孕妇和纳米罗,Burkina Faso的一般人群]]>

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstract For the first time the combined quintuple mutation in the dhps and dhfr gene of Plasmodium falciparum associated with sulfadoxine-pyrimethamine resistance has been found in Burkina Faso. Display Omitted Highlights ? First finding of the quintuple dhfr - dhps mutant in Burkina Faso. ? Limitation of use of ITPp-SP as a preventive measure. ? Need for increased drug resistance monitoring and surveillance in West Africa. Abstract Sulphadoxine-pyrimethamine (SP) is only used for intermittent preventive treatment during pregnancy (IPTp) in most Sub-Saharan African countries. However, there are concerns about the efficacy of IPTp-SP because of increasing resistance. Combinations of point mutations in the dhps and dhfr genes of Plasmodium falciparum are associated with SP resistance, in particular the quintuple dhfr (N51, C59, S108) ? dhps (codons A437, K540) mutant. In Nanoro, Burkina Faso, filter paper samples from pregnant women at first antenatal care visit and at delivery plus samples from the general population (GP) were studied for dhfr and dhps mutations by sequencing. Quintuple mutants were present in 2 delivery and 4 GP samples. This is the first time the quintuple mutation is found in Burkina Faso and although the prevalence is still very low, emergence of the quintuple mutation could highly diminish the efficacy of IPTp-SP. Close surveillance of SP resistance mutations is therefore warranted. ]]>
机译:图解摘要首次在Burkina Faso发现了与磺基甲胺抗性相关的DHPS和DHFR基因的组合Quintup突变,并在Burkina Faso发现了与磺基甲胺抗性相关的。显示省略亮点?在布基纳法索首次发现Quintuple DHFR - DHPS突变体。还ITPP-SP的使用限制作为预防措施。还需要增加西非的耐药监测和监测。摘要磺基砜 - 吡米甲胺(SP)仅用于怀孕期间的间歇性预防治疗(IPTP)在大多数撒哈拉非洲国家。然而,由于阻力越来越大,涉及IPTP-SP的功效。 DHPS和DHFR基因的点突变的组合与SPARCAPARUM的疟原虫基因与SP电阻相关,特别是Quintuple DHFR(N51,C59,S108)? DHPS(密码子A437,K540)突变体。在纳莫罗,Burkina Faso,通过测序研究了第一次出产水护理访问中的孕妇和递送的样品和来自一般人群(GP)的样品进行测序。 Quintuple突变体存在于2次递送和4gP样品中。这是第一次在Burkina Faso中发现Quintule突变,虽然患病率仍然非常低,但Quintuple突变的出现可以高度缩短IPTP-SP的功效。因此,有必要紧密监测SP电阻突变。 ]]>

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号